Vesico-Ureteral Reflux
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Uterine Anomalies
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Ulnar deviation of the fingers
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Tumor Progression
|
0.010 |
PosttranslationalModification
|
phenotype |
BEFREE |
Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
|
28077137 |
2017 |
Tumor Cell Invasion
|
0.020 |
PosttranslationalModification
|
phenotype |
BEFREE |
DACT1 methylation was significantly associated with tumor metastasis (P < 0.05), invasion (P < 0.05) and advanced tumor stage (P < 0.0005).
|
23073659 |
2012 |
Tumor Cell Invasion
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
High expression of DACT1 may inhibit the invasion and metastasis of nasopharyngeal carcinoma cells.
|
31182157 |
2019 |
Triphalangeal thumb
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
TOWNES-BROCKS SYNDROME 2
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Posterior malformations in Dact1 mutant mice arise through misregulated Vangl2 at the primitive streak.
|
19701191 |
2009 |
TOWNES-BROCKS SYNDROME 2
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Heterozygous Pathogenic Variant in DACT1 Causes an Autosomal-Dominant Syndrome with Features Overlapping Townes-Brocks Syndrome.
|
28054444 |
2017 |
TOWNES-BROCKS SYNDROME 2
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Identification of novel rare mutations of DACT1 in human neural tube defects.
|
22610794 |
2012 |
Townes syndrome
|
0.510 |
Biomarker
|
disease |
CTD_human |
|
|
|
Townes syndrome
|
0.510 |
GermlineCausalMutation
|
disease |
ORPHANET |
Together, these findings suggest that the DACT1 c.1256G>A nonsense variant is causative of a specific genetic syndrome with features overlapping Townes-Brocks syndrome.
|
28054444 |
2017 |
Townes syndrome
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
Together, these findings suggest that the DACT1 c.1256G>A nonsense variant is causative of a specific genetic syndrome with features overlapping Townes-Brocks syndrome.
|
28054444 |
2017 |
Tetralogy of Fallot
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Syndactyly of the toes
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Subcutaneous nodule
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Strabismus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Stomach Neoplasms
|
0.010 |
PosttranslationalModification
|
group |
BEFREE |
Moreover, promoter methylation of DACT1 was detected in 29.3% (60/205) of primary gastric tumors.
|
23073659 |
2012 |
Stomach Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.
|
30547803 |
2018 |
Stomach Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Dapper homolog 1 alpha suppresses metastasis ability of gastric cancer through inhibiting planar cell polarity pathway.
|
27833078 |
2016 |
Stomach Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-κB signaling pathway.
|
23073659 |
2012 |
Sternal cleft
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Squamous cell carcinoma of esophagus
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The TSS region hypermethylation may be one of the main mechanisms for reduced expression of DACT1 and DACT2 in ESCC.
|
28077137 |
2017 |
Squamous cell carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression and epigenetic regulation of DACT1 and DACT2 in oral squamous cell carcinoma.
|
25524937 |
2015 |
Spina bifida of cervical region
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|